Variant report
Variant | nsv522577 |
---|---|
Chromosome Location | chr3:21504737-21505480 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs13061028 | chr3:21504737-21504738 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs536355096 | chr3:21504742-21504743 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs200971094 | chr3:21504765-21504766 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs555089051 | chr3:21504778-21504779 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs73131561 | chr3:21504794-21504795 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
6 | rs73131564 | chr3:21504891-21504892 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
7 | rs556483687 | chr3:21504961-21504962 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs578011846 | chr3:21504995-21504996 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs545162152 | chr3:21504999-21505000 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs146683411 | chr3:21505049-21505050 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs115249851 | chr3:21505069-21505070 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs542353975 | chr3:21505105-21505106 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs9852842 | chr3:21505141-21505142 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
14 | rs531191870 | chr3:21505145-21505146 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs185179693 | chr3:21505146-21505147 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs571578915 | chr3:21505157-21505158 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs532695602 | chr3:21505231-21505232 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs547927267 | chr3:21505240-21505241 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs566129424 | chr3:21505274-21505275 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs536900923 | chr3:21505290-21505291 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs17008871 | chr3:21505299-21505300 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
22 | rs570198959 | chr3:21505301-21505302 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs537410772 | chr3:21505317-21505318 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs58120499 | chr3:21505322-21505323 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
25 | rs577964638 | chr3:21505336-21505337 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs539113564 | chr3:21505386-21505387 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs35256846 | chr3:21505387-21505388 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs538566749 | chr3:21505398-21505399 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs554082225 | chr3:21505413-21505414 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs567711671 | chr3:21505441-21505442 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs572125757 | chr3:21505453-21505454 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs163469 | chr3:21505480-21505481 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Esophageal squamous carcinoma | 18405350 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Breast cancer | 17603634 | CNVD |
Neuroblastoma | 17327916 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Colorectal cancer | 21297112 | CNVD |
Lynch syndrome | 18415027 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Melanoma | 18172304 | CNVD |
Cervical cancer | 21062161 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Insulin resistance | 16721378 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Oral cancer | 19627613 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Epithelial cancer | 22065749 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Liposarcoma | 21253554 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Pancreatic endocrine tumor | 20981439 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Oral cancer | 21386901 | CNVD |
Cutaneous squamous cell carcinomas | 19131950 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Retinoblastoma | 21504564 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Lung cancer | 20668451 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Intellectual disability | 22102821 | CNVD |
Esophageal cancer | 20955586 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Gastric adenocarcinoma | 19115996 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Esophageal squamous carcinoma | 17470683 | CNVD |
Breast cancer | 17133270 | CNVD |
Developmental delay | 21147756 | CNVD |
Uveal melanoma | 20484589 | CNVD |
Autism | 22495311 | CNVD |
Cancer | 20164919 | CNVD |
Melanoma | 20688739 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr3:21477000-21507200 | Weak transcription | Fetal Muscle Leg | muscle |
2 | chr3:21489200-21506600 | Weak transcription | Fetal Stomach | stomach |
3 | chr3:21491800-21506800 | Weak transcription | Aorta | Aorta |
4 | chr3:21504000-21519800 | Weak transcription | NHDF-Ad | bronchial |
5 | chr3:21504400-21508200 | Weak transcription | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
6 | chr3:21504800-21505200 | Enhancers | Ovary | ovary |
7 | chr3:21505200-21506200 | Weak transcription | Ovary | ovary |
8 | chr3:21505400-21505600 | Enhancers | Fetal Lung | lung |
9 | chr3:21505400-21506200 | Enhancers | Colon Smooth Muscle | Colon |